Company Filing History:
Years Active: 2014-2019
Title: The Innovations of Adam Belley
Introduction
Adam Belley is an accomplished inventor based in Beaconsfield, CA. He has made significant contributions to the field of antimicrobial treatments, holding two patents that address critical issues in bacterial infections. His work focuses on innovative methods to combat biofilms and improve susceptibility testing for antibiotics.
Latest Patents
Belley’s latest patents include "Methods of inhibiting and treating biofilms using glycopeptide antibiotics." This invention is directed towards methods for inhibiting, delaying formation, and treating infections caused by bacteria that exhibit tolerance to antimicrobial agents. It specifically addresses slow-growing, stationary-phase, and biofilm-forming bacteria through the use of glycopeptide antibiotics, such as oritavancin. Another notable patent is the "Disk diffusion assay for oritavancin," which presents an improved method for determining bacterial susceptibility to glycopeptide antibiotics. This assay enhances conventional methods by incorporating polysorbate 80 and Span 80 in the antibacterial solution used to impregnate paper disks.
Career Highlights
Throughout his career, Adam Belley has worked with notable companies in the pharmaceutical industry, including Melinta Therapeutics, Inc. and The Medicines Company. His experience in these organizations has allowed him to develop and refine his innovative approaches to antibiotic treatments.
Collaborations
Belley has collaborated with esteemed colleagues such as Eve Neesham-Grenon and Gregory Moeck, contributing to the advancement of research in antimicrobial therapies.
Conclusion
Adam Belley’s contributions to the field of antimicrobial treatments through his patents and collaborations highlight his commitment to addressing significant health challenges. His innovative methods and dedication to research continue to impact the medical community positively.